Stay updated on M7824 in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the M7824 in Advanced Solid Tumors Clinical Trial page.

Latest updates to the M7824 in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the completed Phase 1 MSB0011359C (M7824) study is now displayed, including its eligibility criteria, locations, treatment plan, outcome measures, and results-related information.SummaryDifference51%

- Check18 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0, while the study page remains inaccessible with a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide notice announces NIH's transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded new links and downloadable documents (Medical Information Location Map - Med Info Contacts, Trial Awareness and Transparency website, INTR@PID Clinical Trial Program, Merck KGaA, Darmstadt, Germany, Helpful Links, Study Protocol PDF, Statistical Analysis Plan PDF) and updated metadata such as the Last Verified date; Removed a 403 Forbidden page and the Home link to streamline navigation.SummaryDifference53%

Stay in the know with updates to M7824 in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 in Advanced Solid Tumors Clinical Trial page.